No \u0161.g. 13. l\u012bdz 15. oktobrim Grindeks piedal\u012bsies vado\u0161aj\u0101 farm\u0101cijas nozares izst\u0101d\u0113 \u201eCPhI Worldwide 2009″, kas norisin\u0101sies Madrid\u0113, Sp\u0101nij\u0101. Izst\u0101des laik\u0101 Grindeks iepaz\u012bstin\u0101s potenci\u0101los sadarb\u012bbas partnerus ar pasaules kvalit\u0101tes standartiem atbilsto\u0161iem pakalpojumiem akt\u012bvo farmaceitisko vielu (AFV) p\u0113tniec\u012bbas un ra\u017eo\u0161anas jom\u0101, k\u0101 ar\u012b sadarb\u012bbas iesp\u0113j\u0101m gatavo z\u0101\u013cu formu (GZF) izstr\u0101des, ra\u017eo\u0161anas un re\u0123istr\u0101cijas jom\u0101. Grindeks stends b\u016bs izvietots 10. izst\u0101\u017eu hall\u0113 ar numuru 10G41.<\/p>\n\n\n\n
AS Grindeks valdes priek\u0161s\u0113d\u0113t\u0101js J\u0101nis Romanovskis: \u201eGrindeks ir visi nepiecie\u0161amie resursi, lai pied\u0101v\u0101tu rado\u0161us un t\u0101lredz\u012bgus biznesa risin\u0101jumus par konkur\u0113tsp\u0113j\u012bg\u0101m cen\u0101m \u2013 izdev\u012bgs \u0123eogr\u0101fiskais novietojums, v\u0113sturiski izveidojusies un cie\u0161a zin\u0101tnes un industrijas sadarb\u012bbas saikne ar Krieviju, cit\u0101m NVS un Austrumu valst\u012bm, eiropeiska biznesa kult\u016bra, valodu zin\u0101\u0161anas, starptautiskiem standartiem atbilsto\u0161a kvalit\u0101te un augsts zin\u0101tniskais potenci\u0101ls. Pag\u0101ju\u0161\u0101 gad\u0101 piedaloties \u0161aj\u0101 izst\u0101d\u0113, secin\u0101j\u0101m, ka varam p\u0101rliecino\u0161i konkur\u0113t glob\u0101laj\u0101 farm\u0101cijas tirg\u016b un esam uzticams, stabils un kvalitat\u012bvs partneris. \u0160ogad izst\u0101d\u0113 piedal\u012bsimies atk\u0101rtoti, jo tas ir efekt\u012bvs veids, k\u0101 \u0113rti vienuviet satikt klientus no visas pasaules un p\u0101rrun\u0101t turpm\u0101k\u0101s sadarb\u012bbas iesp\u0113jas, prezent\u0113t savu produkciju un pakalpojumus citiem nozares profesion\u0101\u013ciem, veidot jaunus kontaktus, k\u0101 ar\u012b uzzin\u0101t par modern\u0101kajiem izgudrojumiem, tehnolo\u0123ij\u0101m un att\u012bst\u012bbas tendenc\u0113m farm\u0101cijas nozar\u0113.\u201d<\/p>\n\n\n\n
Grindeks stenda apmekl\u0113t\u0101jiem tiks pied\u0101v\u0101ta sadarb\u012bba tr\u012bs jom\u0101s.<\/p>\n\n\n\n
AFV p\u0113tniec\u012bba, izstr\u0101de, ra\u017eo\u0161ana un tirdzniec\u012bba.<\/strong> GZF izstr\u0101de un ra\u017eo\u0161ana.<\/strong> Gatavo z\u0101\u013cu formu re\u0123istr\u0101cijas un m\u0101rketinga pakalpojumi.<\/strong> Grindeks pied\u0101v\u0101 kvalitat\u012bvas eCTD form\u0101t\u0101 sagatavotas dokument\u0101cijas tulko\u0161anu un adapt\u0113\u0161anu atbilsto\u0161i attiec\u012bg\u0101s valsts likumdo\u0161anai, iepakojumu un lieto\u0161anas instrukciju izstr\u0101di, k\u0101 ar\u012b produkta re\u0123istr\u0101ciju attiec\u012bgaj\u0101 tirg\u016b. Grindeks \u013coti labi p\u0101rzina Krievijas, Ukrainas, Baltkrievijas un citu NVS valstu likumdo\u0161anu un pied\u0101v\u0101 z\u0101\u013cu re\u0123istr\u0101cijas veik\u0161anu \u0161aj\u0101s valst\u012bs, k\u0101 ar\u012b medikamentu tirdzniec\u012bbu un virz\u012b\u0161anu attiec\u012bgaj\u0101 tirg\u016b.<\/p>\n\n\n\n \u201eCPhIWorldwide\u201d ir vado\u0161\u0101 izst\u0101de farm\u0101cijas jom\u0101 pasaul\u0113, kur\u0101 piedal\u0101s farmaceitisko produktu ra\u017eot\u0101ji un saist\u012bto nozaru p\u0101rst\u0101vji no visas pasaules. \u0160ogad izst\u0101d\u0113 pl\u0101no piedal\u012bties ~1000 uz\u0146\u0113mumi no 125 valst\u012bm.<\/p>\n\n\n\n Grindeks dal\u012bbu izst\u0101d\u0113 l\u012bdzfinans\u0113 Eiropas re\u0123ion\u0101l\u0101s att\u012bst\u012bbas fonds.<\/p>\n","protected":false},"excerpt":{"rendered":" No \u0161.g. 13. l\u012bdz 15. oktobrim Grindeks piedal\u012bsies vado\u0161aj\u0101 farm\u0101cijas nozares izst\u0101d\u0113 \u201eCPhI Worldwide 2009″, kas norisin\u0101sies Madrid\u0113, Sp\u0101nij\u0101. Izst\u0101des laik\u0101 Grindeks iepaz\u012bstin\u0101s potenci\u0101los sadarb\u012bbas…<\/p>\n","protected":false},"author":3,"featured_media":6601,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-580","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-jaunums"],"acf":[],"_links":{"self":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/580","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/comments?post=580"}],"version-history":[{"count":0,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/580\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media\/6601"}],"wp:attachment":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media?parent=580"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/categories?post=580"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/tags?post=580"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
Grindeks nodro\u0161ina AFV p\u0113tniec\u012bbu un att\u012bst\u012bbu atbilsto\u0161i GMP (Good Manufacturing Practice) standartiem un pied\u0101v\u0101 risin\u0101jumus atbilsto\u0161i specifisk\u0101m klientu pras\u012bb\u0101m. Atbilsto\u0161i GLP (Good Laboratory Practice) standartiem sertific\u0113taj\u0101 jauno AFV anal\u012btisk\u0101s m\u0113rogo\u0161anas laboratorij\u0101 iesp\u0113jams veikt komplic\u0113tu, daudzpak\u0101pju (5-10 pak\u0101pes) AFV sint\u0113zi, galvenok\u0101rt fokus\u0113joties uz ni\u0161as farmaceitiskajiem produktiem. \u0160aj\u0101 laboratorij\u0101 iesp\u0113jams ne tikai p\u0113t\u012bt jaunus produktus, bet ar\u012b veikt \u012bpa\u0161u ni\u0161as produktu ra\u017eo\u0161anu neliel\u0101s s\u0113rij\u0101s, turkl\u0101t izmantojot pasaules l\u012bme\u0146a tehnolo\u0123ijas un par pie\u0146emamu cenu Eiropas kontekst\u0101. Grindeks AFV ra\u017eotnes savuk\u0101rt nodro\u0161ina substan\u010du un starpproduktu ra\u017eo\u0161anu lielos apjomos.<\/p>\n\n\n\n
Grindeks pied\u0101v\u0101 pilna spektra GZF \u2013 table\u0161u, kapsulu un s\u012brupu \u2013 ra\u017eo\u0161anu atbilsto\u0161i klienta individu\u0101lajam pas\u016bt\u012bjumam. Ra\u017eo\u0161ana tiek organiz\u0113ta pasaules farmaceitiskajiem r\u016bpniec\u012bbas standartiem (GMP un ISO) atbilsto\u0161\u0101 ra\u017eotn\u0113, kur\u0101 nodro\u0161in\u0101ts D klases telpu t\u012br\u012bbas l\u012bmenis un uzst\u0101d\u012btas m\u016bsdien\u012bgas un jaud\u012bgas tehnolo\u0123ijas. Ra\u017eotnes jauda ir 1,5 miljardi table\u0161u un 500 miljoni kapsulu gad\u0101. GZF izstr\u0101des jom\u0101 Grindeks pied\u0101v\u0101 produktu tehnolo\u0123ijas izstr\u0101di un ievie\u0161anu ra\u017eo\u0161an\u0101, ra\u017eo\u0161anas procesa un anal\u012b\u017eu meto\u017eu valid\u0101ciju, k\u0101 ar\u012b z\u0101\u013cu re\u0123istr\u0101cijas dokument\u0101cijas izstr\u0101di.<\/p>\n\n\n\n